Primary Performance End Point Met in First Study of Calcivis® Caries Activity Imaging System
Calcivis, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, today announces headline results from the first clinical study of its Calcivis® Caries Activity Imaging System.
The study met its primary performance endpoint relating to the System’s ability to identify early active caries lesions and an excellent safety profile was observed. The study was conducted in 42 patients by four general dental practitioners based in three practices in Scotland. Full results will be published in due course.
The Calcivis Caries Activity Imaging System is a sophisticated medical device and consumable combination designed to transform the assessment and management of dental caries and other dental conditions. It involves a unique, proprietary bioluminescence approach combined with a specialised imaging device which allows accurate detection and visualisation of demineralisation by imaging free calcium ions at the tooth surface; a caries lesion which is actively demineralising is more likely to progress and lead to cavitation. The Calcivis Caries Activity Imaging System has been granted a CE Mark.
